Last 12 months
Inside the activity.
0 purchase rows · 313 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 114 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 16 |
| Feb 2026 | 0 | 55 |
| Mar 2026 | 0 | 9 |
| Apr 2026 | 0 | 24 |
| May 2026 | 0 | 45 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 19 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 10, 2026 Filed Feb 12, 2026 19:45 UTC |
Hsing MichaelDirector · CEO
|
SaleCommon Stock | 1,215 | $1,151.11 | $1,398,598.65 |
DisclosureSEC source: 0001214659-26-001587 · marketforms-72116.xml · nonDerivative · entry 5 Hsing Michael · CIK 0001308676 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 956,448 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/28/2025. F6 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $1,149.04 to $1,154.00. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 19:45 UTC |
Hsing MichaelDirector · CEO
|
SaleCommon Stock | 3,864 | $1,145.90 | $4,427,757.60 |
DisclosureSEC source: 0001214659-26-001587 · marketforms-72116.xml · nonDerivative · entry 4 Hsing Michael · CIK 0001308676 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 957,663 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/28/2025. F5 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $1,144.03 to $1,149.00. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 19:45 UTC |
Hsing MichaelDirector · CEO
|
SaleCommon Stock | 16,080 | $1,141.88 | $18,361,430.40 |
DisclosureSEC source: 0001214659-26-001587 · marketforms-72116.xml · nonDerivative · entry 3 Hsing Michael · CIK 0001308676 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 961,527 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/28/2025. F4 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $1,138.96 to $1,143.96. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 19:45 UTC |
Hsing MichaelDirector · CEO
|
SaleCommon Stock | 6,325 | $1,136.75 | $7,189,943.75 |
DisclosureSEC source: 0001214659-26-001587 · marketforms-72116.xml · nonDerivative · entry 2 Hsing Michael · CIK 0001308676 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 977,607 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/28/2025. F3 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $1,133.92 to $1,138.90. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 19:45 UTC |
Hsing MichaelDirector · CEO
|
SaleCommon Stock | 4,302 | $1,132.01 | $4,869,907.02 |
DisclosureSEC source: 0001214659-26-001587 · marketforms-72116.xml · nonDerivative · entry 1 Hsing Michael · CIK 0001308676 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 983,932 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/28/2025. F2 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $1,128.88 to $1,133.86. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 18:44 UTC |
Lee Victor KDirector
|
SaleCommon Stock | 400 | $1,212.16 | $484,864.00 |
DisclosureSEC source: 0001214659-26-001517 · marketforms-72113.xml · nonDerivative · entry 1 Lee Victor K · CIK 0001292133 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,756 F1 · shares: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/25/2025. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 23:57 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 21,725 | $1,171.16 | $25,443,531.38 |
DisclosureSEC source: 0001214659-26-001448 · marketforms-72090.xml · nonDerivative · entry 1 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,353 F1 · shares: The reported sales were to cover taxes upon the release of restricted stock units, as required by the Company's equity incentive plan. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 23:58 UTC |
Tseng SariaEVP & General Counsel
|
SaleCommon Stock | 22,875 | $1,171.16 | $26,790,369.64 |
DisclosureSEC source: 0001214659-26-001450 · marketforms-72093.xml · nonDerivative · entry 1 Tseng Saria · CIK 0001312593 · EVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,626 F1 · shares: The reported sales were to cover taxes upon the release of restricted stock units, as required by the Company's equity incentive plan. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 23:59 UTC |
Xiao DemingEVP, Global Operations
|
SaleCommon Stock | 22,875 | $1,171.16 | $26,790,369.64 |
DisclosureSEC source: 0001214659-26-001451 · marketforms-72094.xml · nonDerivative · entry 1 Xiao Deming · CIK 0001308647 · EVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,932 F1 · shares: The reported sales were to cover taxes upon the release of restricted stock units, as required by the Company's equity incentive plan. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 23:57 UTC |
Sciammas MauriceEVP, WW Sales & Marketing
|
SaleCommon Stock | 22,875 | $1,171.16 | $26,790,369.64 |
DisclosureSEC source: 0001214659-26-001449 · marketforms-72092.xml · nonDerivative · entry 1 Sciammas Maurice · CIK 0001360833 · EVP, WW Sales & Marketing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,625 F1 · shares: The reported sales were to cover taxes upon the release of restricted stock units, as required by the Company's equity incentive plan. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 23:56 UTC |
Hsing MichaelDirector · CEO
|
SaleCommon Stock | 54,923 | $1,171.16 | $64,323,823.90 |
DisclosureSEC source: 0001214659-26-001447 · marketforms-72091.xml · nonDerivative · entry 1 Hsing Michael · CIK 0001308676 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 988,234 F1 · shares: The reported sales were to cover taxes upon the release of restricted stock units, as required by the Company's equity incentive plan. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 19:39 UTC |
Martinez CarintiaDirector
|
GrantCommon Stock | 189 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-001257 · marketforms-72041.xml · nonDerivative · entry 1 Martinez Carintia · CIK 0001865213 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,067 F1 · shares: On February 3, 2026, the Board of Directors approved the annual restricted stock unit grant to each independent director. The RSU grant will vest one year after the grant date, subject to continued service with the company. Read SEC document |
| February 03, 2026 Filed Feb 6, 2026 01:03 UTC |
Zhou JeffDirector
|
GrantCommon Stock | 189 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-001261 · marketforms-72043.xml · nonDerivative · entry 1 Zhou Jeff · CIK 0001480772 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,800 F1 · shares: On February 3, 2026, the Board of Directors approved the annual restricted stock unit grant to each independent director. The RSU grant will vest one year after the grant date, subject to continued service with the company. Read SEC document |
| February 03, 2026 Filed Feb 6, 2026 00:35 UTC |
BLEGEN THEODOREEVP and CFO
|
GrantCommon Stock | 38,745 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-001255 · marketforms-72009.xml · nonDerivative · entry 1 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,078 F1 · shares: On February 7, 2023, the reporting person was granted performance-based restricted stock units ("PSUs") subject to the achievement of performance conditions over a three-year performance period. On February 3, 2026, the Company's Compensation Committee of the Board of Directors certified and approved the achievement of the performance criteria for the PSUs, which resulted in 38,745 shares being awarded to the reporting person, subject to tax withholdings. All of the shares fully vested and were released on February 3, 2026, pursuant to the grant agreement. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 19:56 UTC |
Lee Victor KDirector
|
GrantCommon Stock | 189 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-001258 · marketforms-72040.xml · nonDerivative · entry 1 Lee Victor K · CIK 0001292133 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,156 F1 · shares: On February 3, 2026, the Board of Directors approved the annual restricted stock unit grant to each independent director. The RSU grant will vest one year after the grant date, subject to continued service with the company. Read SEC document |
| February 03, 2026 Filed Feb 6, 2026 01:04 UTC |
Wynne EileenDirector
|
GrantCommon Stock | 189 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-001262 · marketforms-72042.xml · nonDerivative · entry 1 Wynne Eileen · CIK 0001575706 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,342 F1 · shares: On February 3, 2026, the Board of Directors approved the annual restricted stock unit grant to each independent director. The RSU grant will vest one year after the grant date, subject to continued service with the company. Read SEC document |
| February 03, 2026 Filed Feb 6, 2026 01:01 UTC |
CHANG KUO WEI HERBERTDirector
|
GrantCommon Stock | 189 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-001260 · marketforms-72038.xml · nonDerivative · entry 1 CHANG KUO WEI HERBERT · CIK 0001192171 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 615 F1 · shares: On February 3, 2026, the Board of Directors approved the annual restricted stock unit grant to each independent director. The RSU grant will vest one year after the grant date, subject to continued service with the company. Read SEC document |
| February 03, 2026 Filed Feb 6, 2026 01:00 UTC |
Elmiger Eugen JDirector
|
GrantCommon Stock | 189 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-001259 · marketforms-72039.xml · nonDerivative · entry 1 Elmiger Eugen J · CIK 0001560945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,402 F1 · shares: On February 3, 2026, the Board of Directors approved the annual restricted stock unit grant to each independent director. The RSU grant will vest one year after the grant date, subject to continued service with the company. Read SEC document |
| February 03, 2026 Filed Feb 6, 2026 00:36 UTC |
Xiao DemingEVP, Global Operations
|
GrantCommon Stock | 57,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-001256 · marketforms-72011.xml · nonDerivative · entry 1 Xiao Deming · CIK 0001308647 · EVP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 258,807 F1 · shares: On February 7, 2023, the reporting person was granted performance-based restricted stock units ("PSUs") subject to the achievement of performance conditions over a three-year performance period. On February 3, 2026, the Company's Compensation Committee of the Board of Directors certified and approved the achievement of the performance criteria for the PSUs, which resulted in 57,170 shares being awarded to the reporting person, subject to tax withholdings. All of the shares fully vested and were released on February 3, 2026, pursuant to the grant agreement. Read SEC document |
| February 03, 2026 Filed Feb 6, 2026 00:29 UTC |
Tseng SariaEVP & General Counsel
|
GrantCommon Stock | 57,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-001254 · marketforms-72010.xml · nonDerivative · entry 1 Tseng Saria · CIK 0001312593 · EVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,501 F1 · shares: On February 7, 2023, the reporting person was granted performance-based restricted stock units ("PSUs") subject to the achievement of performance conditions over a three-year performance period. On February 3, 2026, the Company's Compensation Committee of the Board of Directors certified and approved the achievement of the performance criteria for the PSUs, which resulted in 57,170 shares being awarded to the reporting person, subject to tax withholdings. All of the shares fully vested and were released on February 3, 2026, pursuant to the grant agreement. Read SEC document |
| February 03, 2026 Filed Feb 6, 2026 00:07 UTC |
Hsing MichaelDirector · CEO
|
GrantCommon Stock | 136,825 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-001253 · marketforms-72012.xml · nonDerivative · entry 1 Hsing Michael · CIK 0001308676 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,043,157 F1 · shares: On February 7, 2023, the reporting person was granted performance-based restricted stock units ("PSUs") subject to the achievement of performance conditions over a three-year performance period. On February 3, 2026, the Company's Compensation Committee of the Board of Directors certified and approved the achievement of the performance criteria for the PSUs, which resulted in 136,825 shares being awarded to the reporting person, subject to tax withholdings. All of the shares fully vested and were released on February 3, 2026, pursuant to the grant agreement. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 23:56 UTC |
Sciammas MauriceEVP, WW Sales & Marketing
|
GrantCommon Stock | 57,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-001252 · marketforms-72013.xml · nonDerivative · entry 1 Sciammas Maurice · CIK 0001360833 · EVP, WW Sales & Marketing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,500 F1 · shares: On February 7, 2023, the reporting person was granted performance-based restricted stock units ("PSUs") subject to the achievement of performance conditions over a three-year performance period. On February 3, 2026, the Company's Compensation Committee of the Board of Directors certified and approved the achievement of the performance criteria for the PSUs, which resulted in 57,170 shares being awarded to the reporting person, subject to tax withholdings. All of the shares fully vested and were released on February 3, 2026, pursuant to the grant agreement. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 15:10 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 80 | $1,139.49 | $91,159.20 |
DisclosureSEC source: 0001214659-26-001149 · marketforms-71999.xml · nonDerivative · entry 17 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,333 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. F14 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $1,139.44 to $1,139.54. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F15 · balance_after: Ending balance has been adjusted for a one share rounding difference. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 15:10 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 80 | $1,137.81 | $91,024.80 |
DisclosureSEC source: 0001214659-26-001149 · marketforms-71999.xml · nonDerivative · entry 16 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,412 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 15:10 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 120 | $1,136.35 | $136,362.00 |
DisclosureSEC source: 0001214659-26-001149 · marketforms-71999.xml · nonDerivative · entry 15 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,492 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. F13 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $1,136.18 to $1,136.69. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 15:10 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 120 | $1,135.49 | $136,258.80 |
DisclosureSEC source: 0001214659-26-001149 · marketforms-71999.xml · nonDerivative · entry 14 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,612 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. F12 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $1,135.09 to $1,135.71. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 15:10 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 241 | $1,134.41 | $273,392.81 |
DisclosureSEC source: 0001214659-26-001149 · marketforms-71999.xml · nonDerivative · entry 13 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,732 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. F11 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $1,134.00 to $1,134.78. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 15:10 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 379 | $1,133.47 | $429,585.13 |
DisclosureSEC source: 0001214659-26-001149 · marketforms-71999.xml · nonDerivative · entry 12 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,973 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. F10 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $1,133.00 to $1,133.86. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 15:10 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 322 | $1,132.67 | $364,719.74 |
DisclosureSEC source: 0001214659-26-001149 · marketforms-71999.xml · nonDerivative · entry 11 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,352 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. F9 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $1,132.33 to $1,132.84. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 15:10 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 198 | $1,131.70 | $224,076.60 |
DisclosureSEC source: 0001214659-26-001149 · marketforms-71999.xml · nonDerivative · entry 10 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,674 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. F8 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $1,131.38 to $1,131.91. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 15:10 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 320 | $1,130.48 | $361,753.60 |
DisclosureSEC source: 0001214659-26-001149 · marketforms-71999.xml · nonDerivative · entry 9 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,872 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. F7 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $1,130.18 to $1,130.95. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 15:10 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 240 | $1,129.28 | $271,027.20 |
DisclosureSEC source: 0001214659-26-001149 · marketforms-71999.xml · nonDerivative · entry 8 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,192 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. F6 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $1,129.07 to $1,129.60. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 15:10 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 240 | $1,128.43 | $270,823.20 |
DisclosureSEC source: 0001214659-26-001149 · marketforms-71999.xml · nonDerivative · entry 7 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,432 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. F5 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $1,128.32 to $1,128.64. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 15:10 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 80 | $1,127.39 | $90,191.20 |
DisclosureSEC source: 0001214659-26-001149 · marketforms-71999.xml · nonDerivative · entry 6 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,672 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. F4 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $1,127.28 to $1,127.49. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 15:10 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 200 | $1,126.58 | $225,316.00 |
DisclosureSEC source: 0001214659-26-001149 · marketforms-71999.xml · nonDerivative · entry 5 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,752 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. F3 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $1,126.50 to $1,126.71. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 15:10 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 40 | $1,122.56 | $44,902.40 |
DisclosureSEC source: 0001214659-26-001149 · marketforms-71999.xml · nonDerivative · entry 4 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,952 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 15:10 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 80 | $1,120.77 | $89,661.60 |
DisclosureSEC source: 0001214659-26-001149 · marketforms-71999.xml · nonDerivative · entry 3 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,992 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 15:10 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 40 | $1,117.11 | $44,684.40 |
DisclosureSEC source: 0001214659-26-001149 · marketforms-71999.xml · nonDerivative · entry 2 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,072 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 15:10 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 220 | $1,110.58 | $244,327.60 |
DisclosureSEC source: 0001214659-26-001149 · marketforms-71999.xml · nonDerivative · entry 1 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,112 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. F2 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $1,110.14 to $1,110.68. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:33 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 80 | $946.62 | $75,729.60 |
DisclosureSEC source: 0001214659-26-000197 · marketforms-71761.xml · nonDerivative · entry 15 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,332 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:33 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 40 | $945.00 | $37,800.00 |
DisclosureSEC source: 0001214659-26-000197 · marketforms-71761.xml · nonDerivative · entry 14 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,412 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:33 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 650 | $944.35 | $613,827.50 |
DisclosureSEC source: 0001214659-26-000197 · marketforms-71761.xml · nonDerivative · entry 13 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,452 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. F8 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $944.01 to $944.51. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:33 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 539 | $943.71 | $508,659.69 |
DisclosureSEC source: 0001214659-26-000197 · marketforms-71761.xml · nonDerivative · entry 12 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,102 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. F7 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $943.37 to $943.85. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:33 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 74 | $942.42 | $69,739.08 |
DisclosureSEC source: 0001214659-26-000197 · marketforms-71761.xml · nonDerivative · entry 11 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,641 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. F6 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $942.01 to $942.77. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:33 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 406 | $941.60 | $382,289.60 |
DisclosureSEC source: 0001214659-26-000197 · marketforms-71761.xml · nonDerivative · entry 10 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,715 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. F5 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $941.00 to $941.67. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:33 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 40 | $940.03 | $37,601.20 |
DisclosureSEC source: 0001214659-26-000197 · marketforms-71761.xml · nonDerivative · entry 9 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,121 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:33 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 117 | $939.75 | $109,950.75 |
DisclosureSEC source: 0001214659-26-000197 · marketforms-71761.xml · nonDerivative · entry 8 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,161 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. F4 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $939.51 to $939.99. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:33 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 460 | $938.52 | $431,719.20 |
DisclosureSEC source: 0001214659-26-000197 · marketforms-71761.xml · nonDerivative · entry 7 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,278 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. F3 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $938.14 to $938.69. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:33 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 120 | $936.50 | $112,380.00 |
DisclosureSEC source: 0001214659-26-000197 · marketforms-71761.xml · nonDerivative · entry 6 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,738 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:33 UTC |
BLEGEN THEODOREEVP and CFO
|
SaleCommon Stock | 80 | $935.33 | $74,826.40 |
DisclosureSEC source: 0001214659-26-000197 · marketforms-71761.xml · nonDerivative · entry 5 BLEGEN THEODORE · CIK 0001415033 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,858 F1 · shares: These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/26/2025. F2 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $935.08 to $935.57. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.